Showing 1 - 19 results of 19 for search 'Sanambar Sadighi', query time: 0.07s
Refine Results
-
1
Challenges with the Emergency Departments Use among Cancer Patients; a Mini Review by Maryam Beigom Mobasheri, Rahim Behtar, Sanambar Sadighi
Published 2019-05-01
Article -
2
-
3
Cancer Pain: Physical Factors affecting Pain Experience by Mahnoosh Khosravi, Sanambar Sadighi, Kazem Zendehdel, Shaghayegh Moradi, Fatemeh Sadeghi
Published 2016-11-01
Article -
4
-
5
Metformin Efficacy on Proliferation Indices of Tumoral Cells in Non-Diabetic Patients with Invasive Breast Cancer Referring to the Cancer Institute of Iran by Sanambar Sadighi, Maasoumeh Saberian, Bita Behrouzi, Massoome Najafi, Issa Jahanzad, Ramesh Omranipour
Published 2020-04-01
Article -
6
-
7
-
8
-
9
-
10
-
11
Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study by Hosein Kamranzadeh, Reza Manouchehri Ardekani, Amir Kasaeian, Sanambar Sadighi, Somaye Maghsudi, Issa Jahanzad, Nasrollah Maleki
Published 2019-01-01
Article -
12
Retracted: Somatic Mutation in Immunoglobulin Gene Variable Region in Patients with Chronic Lymphoid Leukemia and its Influence on Patients' Prognosis in Iran by Sanambar Sadighi, Issa Jahanzad, Mohammad Ali Mohagheghi, Mahdieh Shokrollahi, Kazem Zendehdel, Mohammad Hojjat-Farsangi, Parviz Kokhaei
Published 2014-06-01
Article -
13
-
14
-
15
-
16
-
17
Recommendations for Management of the Trastuzumab (Herceptin) among Iranian Breast Cancer Patients, A Policy Brief by Mohammad Reza Rouhollahi, Samad Mohammd Nejad, Iraj Harirchi, Behrouz Zarei, Gelavizh Keshtmand, Sanambar Sadighi, Saeid Amanpour, Afshin Abdirad, Parviz Kokhaei, Mehdi Aghili, Farnaz Amoozegar-Hashemi, Mojtaba Vandrajabpour, Kazem Zendehdel
Published 2014-04-01
Article -
18
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency cl... by Abolghasem Allahyari, Ali Ehsanpour, Nafiseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kafi, Safa Najafi
Published 2022-09-01
Article -
19
Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, eq... by Abolghasem Allahyari, Ali Ehsanpour, Behrouz Najafi, Nafseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kaf, Safa Najaf
Published 2022-12-01
Article